Tags

Type your tag names separated by a space and hit enter

Clinical evaluation to assess the safety and efficacy of coded herbal medicine "Dysmo-off" versus allopathic medicine "Diclofenac sodium" for the treatment of primary dysmenorrhea.
J Herb Pharmacother 2006; 6(1):21-39JH

Abstract

The purpose of the present research work was to carry out clinical study on primary dysmenorrhea to comparatively examine the coded herbal drug formulation "Dysmo-off" with authentic allopathic medicine "Diclofenac sodium" (NSAIDs). A random controlled clinical trial was conducted to compare the efficacy and safety of coded herbal medicinal treatments Dysmo-off with Diclofenac sodium/Phenylacetic acid. These evaluations were based on verbal rating scale so as to ascertain the rate of analgesic effects on dysmenorrhoeic pain. The patients were randomly allocated with the ratio of 1:2 for controlled treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) (n = 40) received Diclofenac sodium tablets twice daily for 4 days (50 mg one day prior to and three days after the menstruation), and test treatment with Dysmo-off (n = 80) received powdered Dysmo-off twice daily for four days (5 g one day prior to and three days after the menstruation). Treatment lasted for 4 consecutive menstrual cycles. Hemoglobin, ESR and ultrasound were measured at baseline during study. All subjects were clinically studied and completed the assigned therapy during the period May 2001 to June 2004.

Authors+Show Affiliations

Faculty of Eastern Medicine, Hamdard University, Oasim Ave, Karachi, Pakistan. haddiii@hotmail.comNo affiliation info available

Pub Type(s)

Comparative Study
Controlled Clinical Trial
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

17135158

Citation

Nazar, Halima, and Khan Usmanghani. "Clinical Evaluation to Assess the Safety and Efficacy of Coded Herbal Medicine "Dysmo-off" Versus Allopathic Medicine "Diclofenac Sodium" for the Treatment of Primary Dysmenorrhea." Journal of Herbal Pharmacotherapy, vol. 6, no. 1, 2006, pp. 21-39.
Nazar H, Usmanghani K. Clinical evaluation to assess the safety and efficacy of coded herbal medicine "Dysmo-off" versus allopathic medicine "Diclofenac sodium" for the treatment of primary dysmenorrhea. J Herb Pharmacother. 2006;6(1):21-39.
Nazar, H., & Usmanghani, K. (2006). Clinical evaluation to assess the safety and efficacy of coded herbal medicine "Dysmo-off" versus allopathic medicine "Diclofenac sodium" for the treatment of primary dysmenorrhea. Journal of Herbal Pharmacotherapy, 6(1), pp. 21-39.
Nazar H, Usmanghani K. Clinical Evaluation to Assess the Safety and Efficacy of Coded Herbal Medicine "Dysmo-off" Versus Allopathic Medicine "Diclofenac Sodium" for the Treatment of Primary Dysmenorrhea. J Herb Pharmacother. 2006;6(1):21-39. PubMed PMID: 17135158.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Clinical evaluation to assess the safety and efficacy of coded herbal medicine "Dysmo-off" versus allopathic medicine "Diclofenac sodium" for the treatment of primary dysmenorrhea. AU - Nazar,Halima, AU - Usmanghani,Khan, PY - 2006/12/1/pubmed PY - 2007/2/28/medline PY - 2006/12/1/entrez SP - 21 EP - 39 JF - Journal of herbal pharmacotherapy JO - J Herb Pharmacother VL - 6 IS - 1 N2 - The purpose of the present research work was to carry out clinical study on primary dysmenorrhea to comparatively examine the coded herbal drug formulation "Dysmo-off" with authentic allopathic medicine "Diclofenac sodium" (NSAIDs). A random controlled clinical trial was conducted to compare the efficacy and safety of coded herbal medicinal treatments Dysmo-off with Diclofenac sodium/Phenylacetic acid. These evaluations were based on verbal rating scale so as to ascertain the rate of analgesic effects on dysmenorrhoeic pain. The patients were randomly allocated with the ratio of 1:2 for controlled treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) (n = 40) received Diclofenac sodium tablets twice daily for 4 days (50 mg one day prior to and three days after the menstruation), and test treatment with Dysmo-off (n = 80) received powdered Dysmo-off twice daily for four days (5 g one day prior to and three days after the menstruation). Treatment lasted for 4 consecutive menstrual cycles. Hemoglobin, ESR and ultrasound were measured at baseline during study. All subjects were clinically studied and completed the assigned therapy during the period May 2001 to June 2004. SN - 1522-8940 UR - https://www.unboundmedicine.com/medline/citation/17135158/Clinical_evaluation_to_assess_the_safety_and_efficacy_of_coded_herbal_medicine_"Dysmo_off"_versus_allopathic_medicine_"Diclofenac_sodium"_for_the_treatment_of_primary_dysmenorrhea_ L2 - https://medlineplus.gov/womenshealth.html DB - PRIME DP - Unbound Medicine ER -